Related Experiment Videos
A prospective study of plasma ascorbic acid concentrations and breast cancer (United States)
K Wu1, K J Helzlsouer, A J Alberg
1Department of Epidemiology, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MD 21205, USA.
Objectives:
To investigate the association between prediagnostic plasma ascorbic acid concentrations and subsequent breast cancer risk in a nested case-control study.
Methods:
Female volunteer residents of Washington County, MD, donated 14,625 non-fasting blood samples in 1989. Incident breast cancer cases (n = 115) and controls (n = 115) were matched by age, menopausal status at donation, and date and hour of blood donation.
Results:
Median ascorbic acid concentrations were similar between cases and controls (1.44 mg/dl vs. 1.39 mg/dl. p = 0.78). There was no evidence for a dose-response relationship between higher plasma ascorbic acid concentrations and breast cancer risk [highest vs. lowest fifths: ORadjusted = 0.90, Ptrend = 0.98).
Conclusions:
Findings from this prospective study do not suggest a protective association between prediagnostic plasma ascorbic acid concentrations and breast cancer risk in the subsequent 5 years of follow-up.